SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001387131-20-008176
Filing Date
2020-09-04
Accepted
2020-09-04 09:02:59
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b5_090420.htm 424B5 358763
2 GRAPHIC tnxp424b5090420001.jpg GRAPHIC 6154
3 GRAPHIC tnxp424b5090420002.jpg GRAPHIC 10703
4 GRAPHIC tnxp424b5090420003.jpg GRAPHIC 6154
  Complete submission text file 0001387131-20-008176.txt   391988
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237610 | Film No.: 201160706
SIC: 2834 Pharmaceutical Preparations